Assessing and managing metabolic syndrome and cardiovascular risk in midlife women

Journal of Cardiovascular Nursing

Volumn 28, Issue 2, 2013, Pages 147-156

  Coviello, Jessica Shank ^a   Knobf, M Tish ^a   Laclergue, Sarah ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

abdominal obesity; cardiovascular health in women; cardiovascular risk; metabolic syndrome; perimenopause; prevention; risk; risk assessment; risk reduction behavior; vascular risk

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CLIMACTERIUM; FEMALE; HUMAN; LIFESTYLE; MASS SCREENING; METABOLIC SYNDROME X; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; REFERENCE VALUE; RISK ASSESSMENT; UNITED STATES;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; LIFE STYLE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; PERIMENOPAUSE; PRACTICE GUIDELINES AS TOPIC; REFERENCE VALUES; RISK ASSESSMENT; UNITED STATES;

MLCS; MLOWN;

EID: 84873995744     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0b013e31823cbef8     Document Type: Article

References (37)

1. American Heart Association 2009. Cardiovascular Disease: Women's No. 1 Health Threat. http://www.americanheart .org/downloadable/heart/ 1267456190628TD%20edited %20FINAL%20women%20and%20CVD%2002.15.10.pdf. Accessed August 2, 2010.
2. Lorenzo C, Williams K, Hunt KS, Haffner J. National Cholesterol Education ProgramYAdult Treatment Panel III, International Diabetes Foundation, and the World Health Organization definition of the metabolic syndrome as prediction of incident cardiovascular disease and diabetes. Diabetes Care. 2007;30(8):8-13.
3. American Heart Association. Heart Disease & Stroke Statistics. 2010. http://www.americanheart.org/downloadable/ heart/1265665152970DS- 3241%20HeartStrokeUpdate-2010 .pdf. Accessed August 2, 2010.
4. Creatsas G, Christodoulakos G, Lambrinoudaki I. Cardiovascular disease: Screening and management of the asymptomatic high-risk post-menopausal woman. Maturitas. 2005;52S: S32-S37.
5. Cheung AM, Chaudhry R, Kapral M, Jackevicius C, Robinson G. Perimenopausal and Postmenopausal Health. BMC Womens Health. 2004;4:SIYS23.
6. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women: 2011 update. Circulation. 2011;123:1243-1262.
7. Collins P, Rosano G, Casey C, et al. Management of cardiovascular risk in the perimenopausal women: A consensus statement of European cardiologist and gynecologists. Climacteric. 2007;10(6):508-526.
8. D'Agostino RB, Vasan RS, Pencina M, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation. 2008;117:743-753.
9. Pang XP, Reckelhoff JF. Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens. 2011;20:133-138.
10. Stangl V, Baumann G, Stangl K. Coronary atherogenic risk factors in women. Eur Heart J. 2002;23:1738-1752.
11. The Emerging Risk Factors Collaboration. Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302(4):412-423.
12. Braun LT. Cardiovascular disease strategies for risk assessment and modification. J Cardiovasc Nurs. 2006;21(66): S20-s42.
13. Gorodeski GI. Update on cardiovascular disease in postmenopausal women. Best Pract Res Clin Obstet Gynaecol. 2002;16(3):329-355.
14. Salhotra S, Arora S, Anubhuti S, Trivedi S, Bhattacharjee J. Influence of menopause on biochemical markers of endothelial dysfunctionVa case-control pilot study in North Indian population. Maturitas. 2009;62:166-170.
15. Bittner V. Menopause, age, and cardiovascular risk: A complex relationship. J Am Coll Cardiol. 2009;54(25): 2374-2375.
16. Wildman RP, Colvin AB, Powell LH, et al. Associations of endogenous sex hormones with the vasculature in menopausal women: The Study of Women's Health Across the Nation (SWAN). Menopause. 2008;15(3):414-421.
17. Keneman P. Menopauses, Peri-menopause: Definitions, Terms and Concepts. Oxford: Oxford Press; 2007.
18. Cifkova R, Pitha J, Lejskova M, Lanska V, Secova S. Blood pressure around the menopause: A population study. J Hypertens. 2008;26(10):1976-1982.
19. Crawford SL, Casey VA, Avis N, McKinlay SM. A longitudinal study of weight and the menopause transition: Results from the Massachusetts Women's Health Study. Menopause. 2000;7(2):96-104.
20. Poehlman ET, Tchernof A. Traversing the menopause: Changes in energy expenditure and body composition. Coron Artery Dis. 1998;9:799-803.
21. Panotopoulas G, Raison J, Ruiz JC, Guy-Grande B, Basdevant A. Weight gain at the time of menopause. Hum Reprod. 1997;12:126-133.
22. Smith KR. Exercise can help control body changes during menopause. Health Care Food Nutr. 2005;22(10):10-12.
23. Larney A, Tucot L, Dechene F, Dobin S, Forest JC. Hyperinsulinemia in non-obese women: Reporting a moderate weight gain at the beginning of menopause: A useful early measure of susceptibility to insulin resistance. Menopause. 2010;17(2):321-325.
24. Gespard U. Hyperinsulinemia, a key factor of the metabolic syndrome in postmenopausal women. Maturitas. 2009;62: 362-365.
25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA. 2001; 285:2486-2497.
26. Picard C, Plu-Bureau G, Neves-e-Castro M, Gompel A. Insulin resistance, obesity and breast cancer risk. Maturitas. 2008;60:19-30.
27. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds Risk Score. JAMA. 2007;297:611-619.
28. Dawber TR, Kannel WB. The Framingham Study: An epidemiological approach to coronary heart disease. Circulation. 1966;34:553-555.
29. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403-414.
30. Esposito K, Ciotola M, Giugliano D. Mediterranean diet and the metabolic syndrome. Mol Nutr Food Res. 2007;51: 1268-1274.
31. Brown TM, Sanderson BK, Bittiner V. Drugs are not enough: The metabolic syndromeVa call for intensive therapeutic lifestyle change. J Cardiometab Syndr. 2009;4:20-25.
32. Preventative Cardiovascular Nurses Association. Living Guidelines for Women. Washington, DC: Office of Women's Health, National Heart Lung & Blood Institute; 2011. Adapted from
33. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women: 2011 update. Circulation. 2011; 123:1243-1262.
34. Grundy SM, Cleeman JI, Daniels SR, et al. for the American Heart Association and the National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation. 2005; 112:2735-2752.
35. Babio N, Bullo M, Salas-Salvado J. Mediterranean diet and metabolic syndrome: The evidence. Public Health Nutr. 2009;12(9A):1607-1617.
36. Berger JS, Jordan CS, Lloyd-Jones D, Blumenthal RS. Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol. 2010;55:1169-1177.
37. Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan R. Predicting the 30 year risk of CAD: The Framingham Heart Study. Circulation. 2009;119:3078-3084.